PATH
Menu

Filter browse results




Total results with these characteristics: 71

Page 2 of 2
Press release | July 29, 2009
The PATH Malaria Vaccine Initiative and Crucell announce collaboration to test new adenovirus-based malaria vaccine approach
Press release | June 17, 2009
Seattle Rotary announces partnership with PATH to address malaria in Africa
Announcement | June 09, 2009
Rotary Club of Seattle and PATH partner on malaria control efforts

New initiative builds on 100 years of service and remarkable progress in the fight against malaria

Announcement | May 28, 2009
Phase 3 malaria vaccine trial begins—final testing of RTS,S

African research centers partner with GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative

Press release | April 23, 2009
Phase 1 trial of whole-parasite malaria vaccine to begin

FDA approval for testing in humans watershed moment for unique malaria vaccine approach

Announcement | April 22, 2009
World Malaria Day is April 25

PATH marks the occasion with a week of activities

Press release | February 26, 2009
New collaboration builds on recent malaria antigen discovery
Announcement | December 17, 2008
Center for Strategic and International Studies and PATH highlight Zambia’s success in controlling malaria
Press release | December 08, 2008
Two new studies in the New England Journal of Medicine show malaria vaccine candidate advancing in Africa
Announcement | September 25, 2008
New funding to further malaria vaccine development

Award will accelerate development of a new generation of malaria vaccines

Announcement | September 22, 2008
New data show malaria control efforts having a dramatic impact in Zambia
Announcement | April 21, 2008
First-ever World Malaria Day April 25

PATH marks the occasion with a week of activities

Announcement | March 28, 2008
MVI director to speak about PATH’s malaria work
Press release | March 05, 2008
“Human challenge” tests accelerate search for malaria vaccine
Press release | January 16, 2008
Intercell (ICLL) and the PATH Malaria Vaccine Initiative announce new collaboration for a vaccine against malaria
Press release | January 14, 2008
Ashley Birkett appointed director, Preclinical Research and Development, at the PATH Malaria Vaccine Initiative
Announcement | December 08, 2007
PATH participates in malaria briefings on Capitol Hill

Colleagues share malaria prevention messages with lawmakers

Press release | October 17, 2007
Study published in The Lancet reports that malaria vaccine candidate has promising safety, tolerability profile in infants

First “proof of concept” of world’s most advanced malaria vaccine candidate in African infants shows protection against malaria

Announcement | October 06, 2007
PATH and partners announce encouraging news at the Malaria Forum
Announcement | October 06, 2007
PATH participates in tropical medicine conference

Conference to feature Zambia’s impressive gains in scaling up the fight against malaria

Press release | May 25, 2007
Dr. Christian Loucq named director of PATH Malaria Vaccine Initiative
Announcement | April 25, 2007
PATH commemorates Africa Malaria Day
Announcement | March 05, 2007
Bill & Melinda Gates Foundation visits malaria project in Zambia
Announcement | February 02, 2007
PATH Malaria Vaccine Initiative announces new director of strategy and operations

Christian Loucq, MD, joins MVI leadership team

Press release | December 14, 2006
PATH Malaria Vaccine Initiative announces new partnership to accelerate development of novel malaria vaccine candidate

MVI and Sanaria Inc. to conduct initial safety and test-of-concept trial

Press release | December 13, 2006
New grant to establish an African Regional Learning Community to tackle malaria

Gates Foundation grant supports innovative network to leverage lessons learned in reducing the devastating impact of malaria

Announcement | April 24, 2006
PATH marks Africa Malaria Day
Press release | November 09, 2005
New Partnership Announces Supply of 526,000 Insecticide Treated Bednets and 500,000 Retreatment Tabs for Malaria Week in Zambia

The Malaria Control & Evaluation Partnership in Africa, of Seattle-Based PATH, Helps to Jump Start Malaria Prevention and Control in Zambia; Government of Zambia Announces National Plan to Control Malaria

Press release | October 31, 2005
New Gates funding will enable MVI and GSK Biologicals to complete development of world’s most advanced malaria vaccine candidate

Collaborators will expand clinical evaluation of malaria vaccine candidate in infants in preparation for large-scale efficacy trials

Announcement | September 01, 2005
New challenges and opportunities
Press release | May 19, 2005
New partnership launched to accelerate and evaluate national malaria control program in Africa

Gates Foundation grant of $35 million to Seattle-based PATH launches new initiative to scale up fight against malaria in Zambia

Page 2 of 2